Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference
Quest Diagnostics (NYSE: DGX) announced that Chairman, CEO and President Jim Davis will participate in a fireside chat at the 7th Annual Evercore HealthCONx Conference in Miami. The presentation, scheduled for December 4, 2024, at 3:00 p.m. Eastern Time, will cover the company's strategy, performance, and current market trends.
The session will be webcast live and accessible through Quest's investor relations page at ir.QuestDiagnostics.com. An archived version will be available within 24 hours after the event and remain accessible until January 3, 2025.
Quest Diagnostics (NYSE: DGX) ha annunciato che il Presidente, CEO e Direttore Jim Davis parteciperà a una chiacchierata informale durante la 7ª Conferenza Annuale Evercore HealthCONx a Miami. La presentazione, programmata per il 4 dicembre 2024 alle 15:00 ora orientale, tratterà la strategia dell'azienda, le sue performance e le attuali tendenze di mercato.
La sessione sarà trasmessa in diretta e sarà accessibile attraverso la pagina delle relazioni con gli investitori di Quest all'indirizzo ir.QuestDiagnostics.com. Una versione registrata sarà disponibile entro 24 ore dopo l'evento e rimarrà accessibile fino al 3 gennaio 2025.
Quest Diagnostics (NYSE: DGX) anunció que el Presidente, CEO y Director Jim Davis participará en una charla informal en la 7ª Conferencia Anual Evercore HealthCONx en Miami. La presentación, programada para el 4 de diciembre de 2024 a las 3:00 p.m. hora del Este, cubrirá la estrategia de la empresa, su rendimiento y las tendencias actuales del mercado.
La sesión será transmitida en vivo y estará accesible a través de la página de relaciones con inversores de Quest en ir.QuestDiagnostics.com. Una versión archivada estará disponible dentro de las 24 horas posteriores al evento y permanecerá accesible hasta el 3 de enero de 2025.
Quest Diagnostics (NYSE: DGX)는 의장 겸 CEO이자 사장인 Jim Davis가 마이애미에서 열리는 제7회 Evercore HealthCONx 컨퍼런스에 참여할 것이라고 발표했습니다. 2024년 12월 4일 오후 3시(동부 표준시)로 예정된 이 발표에서는 회사의 전략, 성과 및 현재 시장 동향에 대해 다룰 것입니다.
세션은 실시간 웹캐스트로 진행되며 Quest의 투자자 관계 페이지(ir.QuestDiagnostics.com)를 통해 접근할 수 있습니다. 이벤트 발생 후 24시간 이내에 아카이브 버전이 제공되며 2025년 1월 3일까지 접근 가능할 것입니다.
Quest Diagnostics (NYSE: DGX) a annoncé que le président, directeur général et président Jim Davis participera à une discussion informelle lors de la 7ème Conférence Annuelle Evercore HealthCONx à Miami. La présentation, prévue pour le 4 décembre 2024 à 15h00 heure de l'Est, abordera la stratégie de l'entreprise, ses performances et les tendances actuelles du marché.
La session sera diffusée en direct et accessible via la page des relations investisseurs de Quest à l'adresse ir.QuestDiagnostics.com. Une version archivée sera disponible dans les 24 heures suivant l'événement et restera accessible jusqu'au 3 janvier 2025.
Quest Diagnostics (NYSE: DGX) gab bekannt, dass der Vorsitzende, CEO und Präsident Jim Davis an einem informellen Gespräch auf der 7. jährlichen Evercore HealthCONx-Konferenz in Miami teilnehmen wird. Die Präsentation, die für den 4. Dezember 2024 um 15:00 Uhr Eastern Time geplant ist, wird die Strategie des Unternehmens, seine Leistung und aktuelle Markttrends behandeln.
Die Sitzung wird live übertragen und über die Investor-Relations-Seite von Quest unter ir.QuestDiagnostics.com zugänglich sein. Eine archivierte Version wird innerhalb von 24 Stunden nach der Veranstaltung verfügbar sein und bis zum 3. Januar 2025 zugänglich bleiben.
- None.
- None.
The fireside chat and Q&A session will be webcast live during the conference and will be available on the company's investor relations page which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until January 3, 2025.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-7th-annual-evercore-healthconx-conference-302321119.html
SOURCE Quest Diagnostics
FAQ
When is Quest Diagnostics (DGX) presenting at the Evercore HealthCONx Conference 2024?
How can I watch Quest Diagnostics' (DGX) presentation at the Evercore Conference?
How long will Quest Diagnostics' (DGX) Evercore Conference webcast be available?
What topics will Quest Diagnostics (DGX) discuss at the Evercore HealthCONx Conference?
